Trending

#Azitra

Latest posts tagged with #Azitra on Bluesky

Latest Top
Trending

Posts tagged #Azitra

Preview
Azitra Faces NYSE American Non-Compliance Notice: Implications for Future Operations Azitra, Inc. has received a non-compliance notification from NYSE American concerning their financial standings. This notice could impact their continued operations and listings.

Azitra Faces NYSE American Non-Compliance Notice: Implications for Future Operations #USA #Azitra #ATR-12 #Branford #NYSE_American

1 0 0 0
Preview
Azitra, Inc. Announces Cancellation of 2026 Stockholders Meeting Due to Insufficient Quorum Azitra, Inc. has announced the cancellation of its special meeting originally set for February 2026 due to insufficient stockholder quorum, impacting vital company decisions.

Azitra, Inc. Announces Cancellation of 2026 Stockholders Meeting Due to Insufficient Quorum #United_States #Inc. #Azitra #ATR-12 #Branford #ATR-04

0 0 0 0
Preview
Azitra, Inc. Reveals 2025 Financial Results and Future Business Strategies Azitra, Inc. has announced its financial performance for 2025, highlighting key clinical advancements and future goals in dermatological treatment innovation.

Azitra, Inc. Reveals 2025 Financial Results and Future Business Strategies #USA #dermatology #Azitra #Branford #ATR-04

0 0 0 0
Preview
Azitra Expands Clinical Trial for Skin Rash Treatment at MD Anderson Cancer Center Azitra, Inc. has announced the expansion of its ATR-04 clinical trial to include the prestigious MD Anderson Cancer Center, accelerating opportunities for patient treatment.

Azitra Expands Clinical Trial for Skin Rash Treatment at MD Anderson Cancer Center #United_States #MD_Anderson #Azitra #ATR-04 #Conn

0 0 0 0
Preview
Azitra, Inc. Set to Showcase Innovations at BIO Investment & Growth Summit in 2026 Azitra, Inc. will present at the BIO Investment & Growth Summit in Miami Beach on March 2-3, 2026, highlighting its innovative biopharmaceutical advancements.

Azitra, Inc. Set to Showcase Innovations at BIO Investment & Growth Summit in 2026 #United_States #Miami_Beach #Azitra #ATR-12 #Precision_Dermatology

0 0 0 0
Preview
Azitra Extends Timeline as Shareholder Meeting Reconvenes in Early March - AktieGo AZTR performance by TradingView Azitra, Inc. (NYSE AMERICAN: AZTR) has adjourned its recently convened special shareholder meeting after failing to reach the minimum quorum required to proceed with vo...

Azitra (AZTR) postponed its shareholder meeting after failing to reach quorum. The meeting resumes March 6, 2026.

aktiego.com/azitra-exten...

#Biotech #Healthcare #aktiego #azitra #Community #Innovation #Investing

0 0 0 0
Preview
Azitra Extends Timeline as Shareholder Meeting Reconvenes in Early March - AktieGo AZTR performance by TradingView Azitra, Inc. (NYSE AMERICAN: AZTR) has adjourned its recently convened special shareholder meeting after failing to reach the minimum quorum required to proceed with vo...

Azitra (AZTR) postponed its shareholder meeting after failing to reach quorum. The meeting resumes March 6, 2026, with proposals on share issuance and financing.

aktiego.com/azitra-exten...

#Biotech #Healthcare #aktiego #azitra #Community #Innovation #Investing

0 0 0 0
Preview
Azitra, Inc. to Showcase at Biotech Event with J.P. Morgan Conference Azitra, Inc., a biopharmaceutical firm, will present at the Biotech Showcase, collaborating with the J.P. Morgan Annual Healthcare Conference.

Azitra, Inc. to Showcase at Biotech Event with J.P. Morgan Conference #United_States #San_Francisco #biotechnology #Azitra #ATR-12

0 0 0 0
Preview
Azitra, Inc. Takes Positive Steps Toward NYSE Compliance with New Listing Plan Azitra, Inc. has received notice from NYSE American, approving its plan for compliance with listing standards amid financial challenges. The firm targets innovative dermatology therapies.

Azitra, Inc. Takes Positive Steps Toward NYSE Compliance with New Listing Plan #USA #dermatology #Azitra #Branford #NYSE_American

0 0 0 0
Preview
Azitra, Inc. Secures $1.5 Million for Innovative Dermatology Therapies through Premium Private Placement Azitra, Inc. has announced a successful $1.5 million private placement to advance its clinical programs for precision dermatology.

Azitra, Inc. Secures $1.5 Million for Innovative Dermatology Therapies through Premium Private Placement #United_States #Azitra #ATR-12 #Branford #NYSE_American

0 0 0 0
Preview
Azitra, Inc. Reports Third Quarter 2025 Financial Results and Key Developments Azitra, Inc. has announced its Q3 2025 financial outcomes, highlighting significant advancements in their clinical programs aimed at treating skin diseases.

Azitra, Inc. Reports Third Quarter 2025 Financial Results and Key Developments #United_States #Azitra #Branford #ATR-04 #ATR-01

0 0 0 0
Preview
Azitra, Inc. Reports Promising Preclinical Results for ATR-01 Solution Aiming to Address Ichthyosis Vulgaris Azitra, Inc. has shared positive preclinical findings for its ATR-01 program, targeting ichthyosis vulgaris, a skin disorder impacting millions and offering hope for effective treatment.

Azitra, Inc. Reports Promising Preclinical Results for ATR-01 Solution Aiming to Address Ichthyosis Vulgaris #United_States #Azitra #Branford #ATR-01 #Ichthyosis

0 0 0 0
Preview
Azitra's Participation in Rare Disease Panel Highlights Innovative Dermatology Solutions at Maxim Growth Summit At the Maxim Growth Summit, Azitra, Inc. associates will discuss groundbreaking treatments for rare dermatologic diseases, focusing on innovative therapies for Netherton syndrome.

Azitra's Participation in Rare Disease Panel Highlights Innovative Dermatology Solutions at Maxim Growth Summit #USA #New_York_City #dermatology #Azitra #Netherton_syndrome

0 0 0 0
Preview
Azitra Inc. Faces NYSE American Compliance Challenge: A Path Ahead Azitra Inc. has received a non-compliance notice from NYSE American regarding its stockholder equity, impacting its listing status. The company plans to address these concerns.

Azitra Inc. Faces NYSE American Compliance Challenge: A Path Ahead #United_States #Azitra #ATR-12 #Branford #NYSE_American

0 0 0 0
Preview
Azitra, Inc. Advances Clinical Trial for New Treatment of Dermatologic Toxicities Linked to Cancer Therapies Azitra, Inc. has initiated its Phase 1/2 trial for ATR04-484, targeting skin rashes associated with EGFR inhibitors, addressing a crucial need in oncology.

Azitra, Inc. Advances Clinical Trial for New Treatment of Dermatologic Toxicities Linked to Cancer Therapies #United_States #Azitra #Branford #ATR04-484 #EGFRi

0 0 0 0
Video

We speak with Azitra’s COO Travis Whitfill about EGFRi associated rash and the rationale behind ATR-04.
$AZTR
#Azitra #NethertonSyndrome #RareDisease

1 0 0 0
Preview
Azitra, Inc. Reports Promising Q2 2025 Results and Future Directions in Dermatology Azitra, Inc. shares significant Q2 2025 results and exciting updates on their innovative dermatological therapies, aiming to transform patient care.

Azitra, Inc. Reports Promising Q2 2025 Results and Future Directions in Dermatology #USA #Azitra #ATR-12 #Branford #Netherton_syndrome

0 0 0 0
Preview
Azitra Announces Key Safety Results from Phase 1b Trial Focused on Netherton Syndrome Azitra, Inc. reveals encouraging safety data from its Phase 1b trial for ATR12-351, targeting Netherton syndrome, showcasing promising tolerability in early patient applications.

Azitra Announces Key Safety Results from Phase 1b Trial Focused on Netherton Syndrome #USA #Azitra #Branford #Netherton_syndrome #ATR12-351

0 0 0 0
Preview
Azitra, Inc. Unveils Groundbreaking ATR-04 Clinical Trial Presentation at ASCO 2025 Azitra, Inc. to present groundbreaking clinical trial results for ATR-04 targeting EGFRi-associated rash at ASCO 2025 in Chicago, showcasing innovative cancer treatment.

Azitra, Inc. Unveils Groundbreaking ATR-04 Clinical Trial Presentation at ASCO 2025 #United_States #Chicago #Azitra #Biomarker #EGFRi

0 0 0 0
Preview
Azitra, Inc. Unveils Key Findings at ASGCT on New Cancer Treatment Approach Azitra, Inc. presents promising results on ATR04-484 targeting EGFR inhibitor-associated rash at ASGCT 2025, showcasing innovative cancer therapy.

Azitra, Inc. Unveils Key Findings at ASGCT on New Cancer Treatment Approach #United_States #New_Orleans #Azitra #ASGCT #ATR04-484

0 0 0 0
Preview
Azitra, Inc. Reports Progress on Clinical Trials and Financial Results for Q1 2025 Azitra, Inc. has released its Q1 financial results and updated on its clinical trials for innovative dermatological therapies, including key milestones.

Azitra, Inc. Reports Progress on Clinical Trials and Financial Results for Q1 2025 #United_States #Azitra #ATR-12 #Branford #ATR-04

0 0 0 0
Preview
Azitra, Inc. to Provide Key Update on ATR-04 Program During ASCO 2025 Meeting Azitra, Inc. announces an abstract acceptance for ATR-04-484 clinical trial update at ASCO 2025. They aim to educate oncology professionals about treating EGFR inhibitor-associated rash.

Azitra, Inc. to Provide Key Update on ATR-04 Program During ASCO 2025 Meeting #USA #Azitra #Branford #EGFR_inhibitors #ATR-04-484

0 0 0 0
Preview
Azitra Forms Partnership to Secure Up to $20 Million in Funding for Clinical Development Azitra, Inc. has signed a share purchase agreement with Alumni Capital to fund its innovative dermatology clinical pipeline, aiming to tackle rare skin diseases.

Azitra Forms Partnership to Secure Up to $20 Million in Funding for Clinical Development #USA #Azitra #ATR-12 #Branford #Alumni_Capital

0 0 0 0
Preview
Azitra to Showcase Breakthrough Therapies at Microbiome Times Partnering Forum Azitra, Inc. announces participation in the upcoming Microbiome Times Partnering Forum, featuring innovative therapies for skin diseases, like Netherton syndrome.

Azitra to Showcase Breakthrough Therapies at Microbiome Times Partnering Forum #United_States #Azitra #ATR-12 #Branford #Netherton_syndrome

0 0 0 0
Preview
Azitra, Inc. Reports 2024 Financials and Clinical Advancements in Dermatological Treatments Azitra, Inc. has announced its 2024 financial results, showcasing significant advancements in its clinical trials for innovative dermatology therapies.

Azitra, Inc. Reports 2024 Financials and Clinical Advancements in Dermatological Treatments #United_States #Azitra #ATR-12 #Branford #ATR-04

0 0 0 0
Preview
Azitra, Inc. to Showcase Innovations at BIO CEO Investor Conference in New York City Azitra, Inc., a clinical-stage biopharmaceutical company, announces its presentation at the BIO CEO & Investor Conference on February 10-11, 2025.

Azitra, Inc. to Showcase Innovations at BIO CEO Investor Conference in New York City #United_States #New_York_City #Azitra #ATR-12 #BIO_CEO

0 0 0 0
Preview
Azitra, Inc. Set to Showcase Innovative Dermatology Therapies at The Microcap Conference 2025 Azitra, Inc., a pioneering biopharmaceutical firm, will present its groundbreaking dermatological therapies at The Microcap Conference in Atlantic City.

Azitra, Inc. Set to Showcase Innovative Dermatology Therapies at The Microcap Conference 2025 #United_States #Azitra #ATR-12 #Atlantic_City,_NJ #ATR-04

0 0 0 0
Preview
Azitra, Inc. Announces $1.5 Million Common Stock Public Offering Price Azitra, Inc. is set to raise $1.5 million through a public offering of common stock at $0.30 per share, targeted for use in working capital.

Azitra, Inc. Announces $1.5 Million Common Stock Public Offering Price #USA #Common_Stock #Azitra #ATR-12 #Branford,_Connecticut

0 0 0 0
Preview
Azitra, Inc. Plans New Public Stock Offering for Strategic Growth Azitra, Inc. announces a public offering of common stock to support its innovative dermatological therapies and general corporate needs.

Azitra, Inc. Plans New Public Stock Offering for Strategic Growth #United_States #Biopharmaceutical #Azitra #ATR-12 #Branford

0 0 0 0
Preview
Azitra, Inc. Prepares to Showcase Innovations at Biotech Showcase 2025 Azitra, Inc. will present their cutting-edge therapies at the upcoming Biotech Showcase 2025 in San Francisco, highlighting their innovative technologies.

Azitra, Inc. Prepares to Showcase Innovations at Biotech Showcase 2025 #USA #San_Francisco #Azitra #ATR-12 #Biotech_Showcase

0 0 0 0